Total Hip Arthroplasty With an Uncemented Tapered Femoral Component in Patients Younger than 50 Years
Received 13 April 2009; accepted 25 November 2009. published online 22 February 2010. Corrected Proof
Abstract
The purpose of the present study was to evaluate the outcome of primary uncemented total hip arthroplasty in patients younger than 50 years using the Taperloc (Biomet, Warsaw, Ind) femoral component. We evaluated 94 hips in 79 patients at a mean follow-up of 16 years (range, 11-18.5 years). The average age of the patients at the time of surgery was 36 years (range, 20-49 years). Three femoral components had been revised, none for aseptic loosening. Complete clinical and radiographic follow-up was obtained on the 91 hips that had not undergone femoral component revision. The mean Harris hip score increased from 54 points (range, 20-72) before surgery to 93 points (range, 68-100) at the time of this review. Radiographically, 89 stems (98%) were determined to have fixation by bone ingrowth, 2 (2%) demonstrated stable fibrous ingrowth, and no femoral component was loose. Distal femoral osteolysis was identified in 1 hip (1%). These findings indicate that excellent clinical and radiographic results can be achieved in young patients with the Taperloc femoral component at a mean follow-up of 16 years.
*The Kennedy Center for the Hip and Knee @ Mercy Medical Center, Oshkosh, Wisconsin
†Gundersen Lutheran Medical Center, LaCrosse, Wisconsin
Reprint requests: Jeffrey R. McLaughlin, MD, The Kennedy Center for the Hip and Knee @ Mercy Medical Center, Suite 125, 2700 W. Ninth Ave, Oshkosh, WI 54901.
Benefits or funds were received in partial or total support of the research material described in this article. These benefits or support were received from Biomet, Inc, Warsaw, Ind.